A final rule, released Feb. 1 by the Centers for Medicare and Medicaid Services (CMS), requires medical device and drug manufacturers to report payments to physicians and teaching hospitals. The rule also authorizes CMS to make publicly available information about ownership or investment interests that physicians (or their immediate family members) have in these manufacturers…

This content is for Paid Members only.
Login Register